These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. Rahimi R; Abdollahi M World J Gastroenterol; 2012 Feb; 18(7):589-600. PubMed ID: 22363129 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006 [TBL] [Abstract][Full Text] [Related]
8. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial. Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408 [TBL] [Abstract][Full Text] [Related]
10. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Madisch A; Holtmann G; Plein K; Hotz J Aliment Pharmacol Ther; 2004 Feb; 19(3):271-9. PubMed ID: 14984373 [TBL] [Abstract][Full Text] [Related]
11. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437 [TBL] [Abstract][Full Text] [Related]
12. Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial. Zheng L; Lai Y; Lu W; Li B; Fan H; Yan Z; Gong C; Wan X; Wu J; Huang D; Wang Y; Mei Y; Li Z; Jiang Z; Liu X; Ye J; Yang Y; Huang H; Xiao J Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1285-1292.e1. PubMed ID: 25632806 [TBL] [Abstract][Full Text] [Related]
13. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Achillea wilhelmsii C. Koch capsules on symptom severity and quality of life in patients with irritable bowel syndrome: a randomized, placebo-controlled clinical trial. Derakhshande P; Navabi SJ; Shokoohinia Y; Rouhi-Broujeni H; Deris F; Behbood L; Shahbazi F; Amiri M; Farzaei MH J Complement Integr Med; 2019 Aug; 16(4):. PubMed ID: 31442203 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882 [TBL] [Abstract][Full Text] [Related]
16. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. Portincasa P; Bonfrate L; Scribano ML; Kohn A; Caporaso N; Festi D; Campanale MC; Di Rienzo T; Guarino M; Taddia M; Fogli MV; Grimaldi M; Gasbarrini A J Gastrointestin Liver Dis; 2016 Jun; 25(2):151-7. PubMed ID: 27308645 [TBL] [Abstract][Full Text] [Related]
17. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial. Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845 [TBL] [Abstract][Full Text] [Related]
18. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions. Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study. Rai RR; Dwivedi M; Kumar N Saudi J Gastroenterol; 2014; 20(6):378-82. PubMed ID: 25434320 [TBL] [Abstract][Full Text] [Related]
20. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome]. Tegaserod Clinical Research Group Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]